Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Eliminate explosive peroxides and heavy metals in 1,2,4-triazole synthesis. Our CDMO expertise ensures high-yield, scalable production with 99%+ purity for drug development.
Eliminate anhydrous/oxygen-free requirements in 1,2,4-triazolyl arylamine production. Reduce costs, ensure supply chain stability for API development. Contact us for custom synthesis.
Solve complex tetracyclic indole synthesis challenges with protonic acid catalysis. Achieve 70-97% yields, simplified operations, and cost savings. Partner with NINGBO INNO PHARMCHEM for reliable CDMO solutions.
Discover a green, catalyst-free synthesis for 2-trifluoromethyl quinolines. Eliminate heavy metal residues, reduce equipment costs, and ensure supply chain stability for your pharmaceutical intermediates.
Solve multi-step synthesis challenges for 5-diarylaminobenzimidazole derivatives with this one-step copper-catalyzed method. Achieve 78% yield, reduced waste, and scalable production for photoelectric applications.
Overcome low yield and complex purification in Favipiravir manufacturing. New one-pot method with 65% yield reduces costs and eliminates chromatography. Contact us for scalable production.
Solve your chiral synthesis challenges with this patent-validated method. Achieve >94% ee and 92% yield in mild conditions. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Solve high cost & safety risks in Baloxavir production. New route avoids chiral resolution, 98.7% ee, 84.5% yield. Scale to 100 MT/yr.
Solve low yield and safety issues in chiral indole synthesis. Our CDMO expertise delivers 90-95% ee and 64-98% yield for anti-tumor drug intermediates.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Solve supply chain risks in trifluoromethyl imidazole production with this patent-validated method. Achieve 99% yields using cheap, scalable chemistry. Contact for CDMO solutions.
Discover how nickel/photo-redox catalysis enables 78-83% yield in C-H cross-coupling for pharmaceutical intermediates with 99:1 regioselectivity. Reduce production costs and supply chain risks.
Discover efficient, scalable synthesis of N-N axis chiral bisindoles with >93% ee and 87% yield. Ideal for pharmaceutical R&D and procurement to accelerate prostate cancer drug development.
Solve supply chain risks with metal-free 5-trifluoromethyl-1,2,4-triazole synthesis. No catalysts, low cost, high yield. NINGBO INNO PHARMCHEM scales to 100 MT/yr.
Solve acylation challenges with metal-free photochemistry: 72% yield, no expensive catalysts, and scalable production for drug development. Request a quote today.
Solve high-cost, low-yield issues in Ribociclib production. Our CDMO leverages patent-validated metal-free routes for 99.8% purity, 5-step synthesis, and scalable manufacturing.
Solve low enantioselectivity in copper-catalyzed trifluoromethylation with novel quinoline-bisoxazoline ligands. Achieve >95% ee and 70% yield for chiral beta-trifluoromethyl ketones. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Discover how chiral phase transfer catalysis enables 92% ee and 80% yield in axial chiral isopyrone-indole synthesis for PC-3 tumor cell targeting. Reduce GMP compliance costs and supply chain risks.
Solve supply chain risks with metal-free 5-trifluoromethyl-1,2,4-triazole synthesis. No catalysts, high yield, green chemistry. Scale to 100MT/yr.
Discover a metal-free, one-pot method for 4-quinolone synthesis with 84% yield. Eliminate catalyst costs and complex purification. Contact us for scalable CDMO solutions.